These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16108497)

  • 1. [Interface domain of hepatitis E virus capsid protein homodimer].
    Li SW; He ZQ; Wang YB; Chen YX; Liu RS; Lin J; Gu Y; Zhang J; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):90-8. PubMed ID: 16108497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology].
    Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The full-length and N-terminal deletion of ORF2 protein of hepatitis E virus can dimerize.
    Tyagi S; Jameel S; Lal SK
    Biochem Biophys Res Commun; 2001 Aug; 286(1):214-21. PubMed ID: 11485331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The study of aggregate of the ORF2 peptide of hepatitis E virus expressed in Escherichia coli].
    Li SW; Zhang J; He ZQ; Ge SX; Gu Y; Lin J; Liu RS; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):463-7. PubMed ID: 12385244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immuno-protect study of a hepatitis E virus ORF2 peptide expressed in E. coli].
    Ge S; Zhang J; Huang G; Pang S; Zhou K; Xia N
    Wei Sheng Wu Xue Bao; 2003 Feb; 43(1):35-42. PubMed ID: 16276869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A yeast two-hybrid study on self-association of the ORF2 protein of hepatitis E virus.
    Tyagi S; Jameel S; Lal SK
    Biochem Biophys Res Commun; 2001 Jun; 284(3):614-21. PubMed ID: 11396945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus.
    Zhou YH; Purcell RH; Emerson SU
    Vaccine; 2005 May; 23(24):3157-65. PubMed ID: 15837215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analysis of Sindbis virus capsid mutants involving assembly and catalysis.
    Choi HK; Lee S; Zhang YP; McKinney BR; Wengler G; Rossmann MG; Kuhn RJ
    J Mol Biol; 1996 Sep; 262(2):151-67. PubMed ID: 8831786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein.
    Zhang J; Gu Y; Ge SX; Li SW; He ZQ; Huang GY; Zhuang H; Ng MH; Xia NS
    Vaccine; 2005 Apr; 23(22):2881-92. PubMed ID: 15780737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells.
    Robinson RA; Burgess WH; Emerson SU; Leibowitz RS; Sosnovtseva SA; Tsarev S; Purcell RH
    Protein Expr Purif; 1998 Feb; 12(1):75-84. PubMed ID: 9473460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Particulate recombinant hepatitis E virus capsid protein and its antigenicity and immunogenicity].
    He ZQ; Zhang J; Li SW; Lin J; Liu RS; Chen YX; Wang YB; Xia NS
    Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):262-8. PubMed ID: 15969119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M.
    Ma H; Song X; Li Z; Harrison TJ; Zhang H; Huang W; Hao W; Kong W; Wang Y
    J Med Virol; 2009 Jun; 81(6):1052-61. PubMed ID: 19382255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
    Neira JL
    FEBS J; 2009 Nov; 276(21):6110-7. PubMed ID: 19825045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4.
    Zhou YH; Purcell RH; Emerson SU
    Vaccine; 2004 Jun; 22(20):2578-85. PubMed ID: 15193383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of the neutralization epitope(s) of the hepatitis E virus.
    Meng J; Dai X; Chang JC; Lopareva E; Pillot J; Fields HA; Khudyakov YE
    Virology; 2001 Sep; 288(2):203-11. PubMed ID: 11601892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis and antigenic activity of peptides from the ORF3 protein sequence of hepatitis E virus].
    Semiletov IuA; Dement'evaEV ; Iashina TL; Favorov MO; Shibnev VA
    Bioorg Khim; 1995 Feb; 21(2):156-7. PubMed ID: 7748209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of a soluble hepatitis E open reading frame 2-derived protein with unique antigenic properties.
    McAtee CP; Zhang Y; Yarbough PO; Bird T; Fuerst TR
    Protein Expr Purif; 1996 Sep; 8(2):262-70. PubMed ID: 8812876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ORF3 protein of hepatitis E virus interacts with hemopexin by means of its 26 amino acid N-terminal hydrophobic domain II.
    Ratra R; Kar-Roy A; Lal SK
    Biochemistry; 2008 Feb; 47(7):1957-69. PubMed ID: 18211098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E virus: a brief review of the biology, molecular virology, and immunology of a novel virus.
    Bradley DW
    J Hepatol; 1995; 22(1 Suppl):140-5. PubMed ID: 7602068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of hepatitis E viral particle.
    Mori Y; Matsuura Y
    Virus Res; 2011 Oct; 161(1):59-64. PubMed ID: 21440590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.